Rangering i aksjer
#15689
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Pris ILM1 pris med markedsverdi på B
Markedsverdi av Medios AG(ILM1)
Markedsverdi: $337.03M
Per September 2026 har Medios AG en markedsverdi på $337.03M. Dette gjør Medios AG til det 15689th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Medios AG fra 2007 til 2026
ILM1 sammenlignet med topp 5 mest populære stocks
| Pris på ILM1 |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.311T
|
+1,575,721.30%
|
|
|
|
|
$4.768T
|
+1,414,543.31%
|
|
|
|
|
$4.039T
|
+1,198,198.38%
|
|
|
|
|
$3.723T
|
+1,104,610.88%
|
|
|
|
|
$2.736T
|
+811,770.07%
|
